These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27832976)

  • 21. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Segarra-Newnham M; Church TJ
    Ann Pharmacother; 2012 Dec; 46(12):1678-87. PubMed ID: 23232021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Patel DA; Shorr AF; Chastre J; Niederman M; Simor A; Stephens JM; Charbonneau C; Gao X; Nathwani D
    Crit Care; 2014 Jul; 18(4):R157. PubMed ID: 25053453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
    Luna CM; Bruno DA; García-Morato J; Mann KC; Risso Patrón J; Sagardía J; Absi R; García Bottino M; Marchetti D; Famiglietti A; Baleztena M; Biancolini C
    Chest; 2009 Jun; 135(6):1564-1571. PubMed ID: 19141525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
    Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Daniel Mullins C; Kuznik A; Shaya FT; Obeidat NA; Levine AR; Liu LZ; Wong W
    Clin Ther; 2006 Aug; 28(8):1184-1198. PubMed ID: 16982296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of linezolid to ventilator-associated pneumonia in Colombia.
    Buendía JA; Patiño DG; Zuluaga Salazar AF
    BMC Infect Dis; 2024 Jan; 24(1):98. PubMed ID: 38238670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study.
    Watanabe A; Goto H; Soma K; Kikuchi T; Gomi K; Miki H; Maemondo M; Ikeda H; Kuroki J; Wada H; Yokoyama T; Izumi S; Mitsutake K; Ueda Y
    J Infect Chemother; 2012 Apr; 18(2):160-8. PubMed ID: 22041987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia.
    Shimazaki N; Hayashi H; Umeda K; Aoyama T; Iida H; Matsumoto Y
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):534-41. PubMed ID: 20650045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
    Liu P; Capitano B; Stein A; El-Solh AA
    BMC Nephrol; 2017 May; 18(1):168. PubMed ID: 28532398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus.
    Kato H; Hagihara M; Asai N; Shibata Y; Koizumi Y; Yamagishi Y; Mikamo H
    J Glob Antimicrob Resist; 2021 Mar; 24():98-105. PubMed ID: 33401013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.
    Yayan J; Ghebremedhin B; Rasche K
    PLoS One; 2015; 10(9):e0138895. PubMed ID: 26398276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.
    Choi EY; Huh JW; Lim CM; Koh Y; Kim SH; Choi SH; Kim YS; Kim MN; Hong SB
    Intensive Care Med; 2011 Apr; 37(4):639-47. PubMed ID: 21253703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.
    Walkey AJ; O'Donnell MR; Wiener RS
    Chest; 2011 May; 139(5):1148-1155. PubMed ID: 20864609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
    Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
    J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.
    Jiang H; Tang RN; Wang J
    Eur J Clin Microbiol Infect Dis; 2013 Sep; 32(9):1121-8. PubMed ID: 23568605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.